Inventor

JENS FRITSCHE

Inventor

DE

Overview

2021–2025

Patent span

Chemistry

Primary field (CPC C)

Patents· 224 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Kprimary

C07KPeptides17%

A61KPreparations for medical, dental or toiletry purposes17%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations17%

C12NMicroorganisms or enzymes17%

G01NInvestigating or analysing materials by determining their chemical or physical properties11%

C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms9%

C12YEnzymes4%

G16BBioinformatics, i.e. information and communication technology [ict] specially adapted for genetic or protein-related data processing in computational molecular biology3%

C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture2%

A01NPreservation of bodies of humans or animals or plants or parts thereof2%

PatentTitleYear

12,480,958Method for the characterization of peptide:MHC binding polypeptides2025 12,351,616Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers2025 12,318,407Peptides displayed by HLA for use in immunotherapy against different types of cancers2025 12,295,994Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers2025 12,295,995Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers2025 12,295,996Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers2025 12,297,254Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers2025 12,297,245Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers2025 12,297,252T cell receptors with improved pairing2025 12,290,530Peptides displayed by HLA for use in immunotherapy against different types of cancers2025 12,285,443Peptides displayed by HLA for use immunotherapy against different types of cancers2025 12,281,146Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers2025 12,274,716Peptides displayed by HLA for use immunotherapy against different types of cancers2025 12,275,776Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers2025 12,275,768In immunotherapy against lung cancer, including NSCLC, SCLC and other cancers2025 12,275,775Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers2025 12,257,269Peptides displayed by HLA for use in immunotherapy against different types of cancers2025 12,258,382Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers2025 12,246,039Peptides displayed by HLA for use in immunotherapy against different types of cancers2025 12,247,057Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers2025 12,240,878Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers2025 12,240,877Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers2025 12,234,276Uterine cancer treatments2025 12,226,466Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers2025 12,226,467Peptides and combination of peptides for use in immunotherapy against various cancers2025 12,227,556Immunotherapy with B*08 restricted peptides and combination of peptides against cancers and related methods2025 12,221,626Peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carcinoma (RCC) and other cancers2025 12,221,468Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers2025 12,221,467Uterine cancer treatments2025 12,214,025Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers2025 12,202,878Immunotherapy with B*07 restricted peptides and combination of peptides against cancers and related methods2025 12,195,507Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers2025 12,195,516Immunotherapy with B*07 restricted peptides and combination of peptides against cancers and related methods2025 12,193,998Peptides and combination of peptides for use in immunotherapy against various cancers2025 12,193,999Peptides and combination of peptides for use in immunotherapy against various cancers2025 12,193,997Peptides and combination of peptides for use in immunotherapy against various cancers2025 12,195,508Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers2025 12,195,506Immunotherapy with A*01 restricted peptides and combination of peptides against cancers and related methods2025 12,195,509Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers2025 12,186,276Peptides and combination of peptides for use in immunotherapy against various cancers2025 12,186,277Peptides and combination of peptides for use in immunotherapy against various cancers2025 12,180,256Peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (CRC) and other cancers2024 12,180,259Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers2024 12,173,043Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers2024 12,171,819Peptides and combination of peptides for use in immunotherapy against various cancers2024 12,168,043Peptides and combination of peptides for use in immunotherapy against various cancers2024 12,162,917B*44 restricted peptides for use in immunotherapy against cancers and related methods2024 12,156,905CCR8 peptide and T cells for use in immunotherapeutic treatment of various cancers2024 12,150,979Peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (CRC) and other cancers2024 12,144,852Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers2024 12,121,572Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers2024 12,103,984Peptides, combination of peptides, and cell based medicaments for use in immunotherapy against urinary bladder cancer and other cancers2024 12,102,670Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers2024 12,097,248Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers2024 12,097,249Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers2024 12,084,486Immunotherapy with B*07 restricted peptides and combination of peptides against cancers and related methods2024 12,084,522Peptides, combination of peptides, and cell based medicaments for use in immunotherapy against urinary bladder cancer and other cancers2024 12,076,381Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers2024 12,076,379A*03 restricted peptides for use in immunotherapy against cancers and related methods2024 12,076,380Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers2024 12,071,458Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers2024 12,070,491Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers2024 12,064,465Immunotherapy against several tumors including gastrointestinal and gastric cancer2024 12,065,471B*44 restricted peptides for use in immunotherapy against cancers and related methods2024 12,060,400Peptides for use in immunotherapy against cancers2024 12,059,458Peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carcinoma (RCC) and other cancers2024 12,060,406Peptides and combination of peptides for use in immunotherapy against various tumors2024 12,060,399Immunotherapy with A*01 restricted peptides and combination of peptides against cancers and related methods2024 12,036,271Peptides and combination of peptides as targets or active ingredients for use in immunotherapy against AML and other cancers2024 12,029,785GINS2 peptide and T cells for use in immunotherapeutic treatment of various cancers2024 12,023,372Peptides and T cells for use in immunotherapeutic treatment of various cancers2024 12,018,064Peptides and combination of peptides for use in immunotherapy against various tumors2024 12,006,349Peptides and combination of peptides for use in immunotherapy against various tumors2024 12,005,105Peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carcinoma (RCC) and other cancers2024 11,999,774Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers2024 11,975,042Immunotherapy against several tumors including gastrointestinal and gastric cancer2024 11,975,058Peptides and T cells for use in immunotherapeutic treatment of various cancers2024 11,969,464Amidated peptides and their deamidated counterparts displayed by HLA-A*02 for use in immunotherapy against different types of cancers2024 11,969,455Immunotherapy against several tumors including gastrointestinal and gastric cancer2024 11,965,013Peptides and combination of peptides for use in immunotherapy against various tumors2024 11,957,730Immunotherapy against several tumors including gastrointestinal and gastric cancer2024 11,957,742Method for treating non-small lung cancer with a population of activated T cells2024 11,957,716Peptides displayed by HLA for use in immunotherapy against different types of cancers2024 11,951,160Peptides and T cells for use in immunotherapeutic treatment of various cancers2024 11,951,132Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers2024 11,952,409Amidated peptides and their deamidated counterparts displayed by non-HLA-A*02 for use in immunotherapy against different types of cancers preliminary class2024 11,945,850B*44 restricted peptides for use in immunotherapy against cancers and related methods2024 11,939,401Immunotherapy against several tumors including lung cancer2024 11,939,400Immunotherapy against several tumors including lung cancer2024 11,938,176Peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carcinoma (RCC) and other cancers2024 11,939,366Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers2024 11,932,678Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers2024 11,918,607Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers2024 11,912,748Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers2024 11,912,749Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers2024 11,905,319Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers2024 11,904,003Amidated peptides and their deamidated counterparts displayed by HLA-A*02 for use in immunotherapy against different types of cancers2024 11,897,934Peptides and combination of peptides for use in immunotherapy against various tumors2024 11,897,936Peptides, combination of peptides as targets and for use in immunotherapy2024 11,897,935Peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers2024 11,891,427Amidated peptides and their deamidated counterparts displayed by non-HLA-a*02 for use in immunotherapy against different types of cancers2024 11,890,334Personalized immunotherapy against several neuronal and brain tumors2024 11,890,333Personalized immunotherapy against several neuronal and brain tumors2024 11,883,462Immunotherapy against several tumors including gastrointestinal and gastric cancer2024 11,872,270A*03 restricted peptides for use in immunotherapy against cancers and related methods2024 11,873,329Peptides and combination of peptides for use in immunotherapy against various tumors2024 11,866,517Immunotherapy against several tumors including lung cancer2024 11,866,473Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers2024 11,859,017Immunotherapy against several tumors including lung cancer2024 11,850,274Immunotherapy against several tumors including gastrointestinal and gastric cancer2023 11,839,643Immunotherapy against several tumors including gastrointestinal and gastric cancer2023 11,833,193A*03 restricted peptides for use in immunotherapy against cancers and related methods2023 11,833,194Peptides and combination of peptides for use in immunotherapy against various cancers2023 11,833,195Amidated peptides and their deamidated counterparts displayed by HLA-A*02 for use in immunotherapy against different types of cancers2023 11,826,410Peptides and combination of peptides for use in immunotherapy against various cancers2023 11,826,409Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers2023 11,814,446Immunotherapy against several tumors including lung cancer2023 11,801,264Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers2023 11,793,866Peptides and T cells for use in immunotherapeutic treatment of various cancers2023 11,786,584Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers2023 11,786,583Peptides and combination of peptides for use in immunotherapy against Hepatocellular carcinoma (HCC) and other cancers2023 11,779,605Immunotherapy with b*08 restricted peptides and combination of peptides against cancers and related methods2023 11,779,606Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers2023 11,779,638Method of eliciting a CD8+ cytotoxic response in hepatocellular carcinoma patients with a population of activated T cells2023 11,759,507Personalized immunotherapy against several neuronal and brain tumors2023 11,744,882Peptides and T cells for use in immunotherapeutic treatment of various cancers2023 11,732,021Immunotherapy with B*07 restricted peptides and combination of peptides against cancers and related methods2023 11,702,460Peptides and combination of peptides for use in immunotherapy against various tumors2023 11,685,769Peptides for use in immunotherapy against cancers2023 11,679,147Method of eliciting a CD8+ cytotoxic response in hepatocellular carcinoma patients with a population of activated T cells2023 11,680,089B*44 restricted peptides for use in immunotherapy against cancers and related methods2023 11,673,917Peptides, combination of peptides, and cell based medicaments for use in immunotherapy against urinary bladder cancer and other cancers2023 11,672,848Method of eliciting a CD8+ cytotoxic response in hepatocellular carcinoma patients with a population of activated T cells2023 11,667,685B*44 restricted peptides for use in immunotherapy against cancers and related methods2023 11,655,281Immunotherapy with B*07 restricted peptides and combination of peptides against cancers and related methods2023 11,655,280Immunotherapy with B*07 restricted peptides and combination of peptides against cancers and related methods2023 11,648,292Immunotherapy against several tumors including gastrointestinal and gastric cancer2023 11,629,177B*44 restricted peptides for use in immunotherapy against cancers and related methods2023 11,618,774Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers2023 11,607,446Personalized immunotherapy against several neuronal and brain tumors2023 11,608,370Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers2023 11,603,397Immunotherapy with B*07 restricted peptides and combination of peptides against cancers and related methods2023 11,597,752Peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (CRC) and other cancers2023 11,576,954Method for treating non-small lung cancer with a population of activated cells2023 11,576,955A*03 restricted peptides for use in immunotherapy against cancers and related methods2023 11,576,956Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers2023 11,559,572Peptides and T cells for use in immunotherapeutic treatment of various cancers2023 11,559,573Method of eliciting a CD8+ cytotoxic response in hepatocellular carcinoma patients with a population of activated T cells2023 11,554,164A*03 restricted peptides for use in immunotherapy against cancers and related methods2023 11,547,750Peptides and T cells for use in immunotherapeutic treatment hepatocellular carcinoma2023 11,541,107Peptides and T cells for use in immunotherapeutic treatment of various cancers2023 11,529,400Personalized immunotherapy against several neuronal and brain tumors2022 11,529,401Personalized immunotherapy against several neuronal and brain tumors2022 11,524,059Personalized immunotherapy against several neuronal and brain tumors2022 11,498,948Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers2022 11,485,769Peptides and combination of peptides for use in immunotherapy and methods for generating scaffolds for the use against pancreatic cancer and other cancers2022 11,485,765Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers2022 11,479,594Peptides and combination of peptides for use in immunotherapy and methods for generating scaffolds for the use against pancreatic cancer and other cancers2022 11,479,589Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers2022 11,466,072Peptides and combination of peptides for use in immunotherapy against various tumors2022 11,459,365Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers2022 11,459,366Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers2022 11,459,371Peptides and combination of peptides for use in immunotherapy against various tumors2022 11,440,947Peptides and combination of peptides for use in immunotherapy against various tumors2022 11,434,273Peptides and combination of peptides for use in immunotherapy against various tumors2022 11,433,124Peptides and combination of peptides for use in immunotherapy against various cancers2022 11,434,274Peptides and combination of peptides for use in immunotherapy against various tumors2022 11,433,099Immunotherapy with B*08 restricted peptides and combination of peptides against cancers and related methods2022 11,427,622Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers2022 11,414,473Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers2022 11,414,472Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers2022 11,414,470Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers2022 11,414,471Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers2022 11,407,809Peptides and combination of peptides for use in immunotherapy against various tumors2022 11,406,693Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers2022 11,407,798Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers2022 11,407,810Peptides and combination of peptides for use in immunotherapy against various tumors2022 11,407,808Peptides and combination of peptides for use in immunotherapy against various tumors2022 11,407,807Peptides and combination of peptides for use in immunotherapy against various tumors2022 11,401,319Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers2022 11,401,310Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers2022 11,390,660Uterine cancer treatments2022 11,384,128Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers2022 11,384,129Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers2022 11,384,127Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers2022 11,376,281Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers2022 11,369,636Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers2022 11,370,817Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers2022 11,365,234Peptides and combination of peptides for use in immunotherapy against various tumors2022 11,365,235Peptides and combination of peptides for use in immunotherapy against various tumors2022 11,357,797Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers2022 11,359,003Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers2022 11,352,401Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers2022 11,332,512Peptides and combination of peptides for use in immunotherapy against various tumors2022 11,324,812Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancers2022 11,298,404Immunotherapy against several tumors including gastrointestinal and gastric cancer2022 11,292,821Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers2022 11,279,740Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers2022 11,279,741Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers2022 11,273,200Immunotherapy against several tumors including gastrointestinal and gastric cancer2022 11,260,115Peptides and combination of peptides for use in immunotherapy against CLL and other cancers2022 11,261,224Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers2022 11,246,917A*03 restricted peptides for use in immunotherapy against cancers and related methods2022 11,235,041Peptides and combination of peptides for use in immunotherapy against various cancers2022 11,235,042Peptides and combination of peptides for use in immunotherapy against various cancers2022 11,230,581Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers2022 11,224,644Peptides and combination of peptides for use in immunotherapy against various cancers2022 11,214,604Peptides for use in immunotherapy against cancers2022 11,208,448B*44 restricted peptides for use in immunotherapy against cancers and related methods2021 11,208,449Peptides for use in immunotherapy against cancers2021 11,197,892Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers2021 11,180,532Peptides, combination of peptides, and cell based medicaments for use in immunotherapy against urinary bladder cancer and other cancers2021 11,179,418Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers2021 11,161,877Immunotherapy against several tumors including lung cancer2021 11,161,880Immunotherapy against several tumors, such as lung cancer, including NSCLC2021 11,161,879Immunotherapy against several tumors, such as lung cancer, including NSCLC2021 11,161,878Immunotherapy against several tumors including lung cancer2021 11,154,576Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers2021 11,155,597Relaxin1 derived peptides for use in immunotherapy2021 11,155,590B*44 restricted peptides for use in immunotherapy against cancers and related methods2021 11,147,838Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers2021 11,147,839Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers2021 11,142,556Immunotherapy with A*01 restricted peptides and combination of peptides against cancers and related methods2021 11,141,437Peptides and combination of peptides of non- canonical origin for use in immunotherapy against different types of cancers2021

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2021–2025Patents assigned to IMMATICS BIOTECHNOLOGIES GMBH (224)· patent assignee history

2021–2025Based in DE· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
IMMATICS BIOTECHNOLOGIES GMBH	224	2021–2025

Locations

Location	Patents	Span
DE	224	2021–2025